S-Space College of Medicine/School of Medicine (의과대학/대학원) Urology (비뇨기과학전공) Journal Papers (저널논문_비뇨기과학전공)
Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities
- Byun, Seok-Soo; Kim, Soo W; Choi, Hwang; Lee, Chongwook; Lee, Eunsik
- Issue Date
- Blackwell Science
- BJU Int. 2005 May;95(7):1086-90.
- Antineoplastic Agents/*therapeutic use; Cisplatin/*therapeutic use; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors/pharmacology; Glutathione/*antagonists & inhibitors; Glutathione Transferase/*antagonists & inhibitors; Humans; Tumor Cells, Cultured; Urinary Bladder Neoplasms/*drug therapy/enzymology
- OBJECTIVES: To investigate the roles of glutathione and glutathione-S-transferase (GST) in cisplatin-resistance mechanisms in human bladder cancer, by using glutathione-depleting or GST-blocking agents. MATERIALS AND METHODS: Cisplatin-resistant human bladder cancer cell lines were established by continuous exposure of T24 cells to increasing concentrations of cisplatin. Buthionine sulphoximine (BSO), ethacrynic acid and indomethacin were used to deplete glutathione or block GST. Intracellular glutathione content, GST activity and cisplatin cytotoxicity were determined after exposing parental and drug-resistant cell lines to these agents. RESULTS: Intracellular glutathione content and GST activity were significantly decreased, and cisplatin cytotoxicity significantly enhanced, in both parental and resistant cell lines by glutathione-depleting or GST-blocking agents. However, the resistance of cisplatin-resistant cell lines did not fully recover to that of the parental cells with combined BSO and indomethacin. CONCLUSIONS: Both increased glutathione content and GST activity are significant in the cisplatin resistance of human bladder tumour cells. Because BSO, ethacrynic acid and indomethacin caused a partial recovery of resistance in the cisplatin-resistant cell line, further studies are needed to investigate their efficacy for treating patients with metastatic bladder carcinoma resistant to cisplatin.
- 1464-4096 (Print)
- Files in This Item: There are no files associated with this item.